Innoviva (INVA) Short-term Investments (2010 - 2026)
Innoviva's (INVA) quarterly Short-term Investments came in at $282000.0 in Q3 2022, down 92.95% on a QoQ basis from $4.0 million in Q2 2020.
Analysis
Innoviva (INVA) Short-term Investments (2010 - 2026) Analysis & Trends
Innoviva (INVA) has 12 years of Short-term Investments data on file, last reported at $282000.0 in Q3 2022.
- Quarterly Short-term Investments changed N/A year-over-year to $282000.0 in Q3 2022, while the trailing twelve-month figure through Sep 2022 was $282000.0 (changed N/A YoY) and the FY2022 annual result came in at $282000.0, changed N/A from the prior year.
- Short-term Investments slipped to $282000.0 in Q3 2022, from $4.0 million in the prior quarter.
- In the past five years, Short-term Investments ranged from a high of $127.0 million in Q1 2019 to a low of $282000.0 in Q3 2022.
- A 4-year average of $52.5 million and a median of $32.0 million in 2020 frame the typical range for Short-term Investments.
- Annual changes were most pronounced in 2019 — Short-term Investments surged 1709.98% — and 2020, when it sank 96.29%.
- Tracing INVA's Short-term Investments over 4 years: stood at $52.5 million in 2018, then surged by 38.59% to $72.7 million in 2019, then sank by 94.5% to $4.0 million in 2020, then sank by 92.95% to $282000.0 in 2022.
- The last three Short-term Investments figures came in at $282000.0 (Q3 2022), $4.0 million (Q2 2020), and $32.0 million (Q1 2020), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Innoviva | 1.56 Bn | 984.81 Mn | 90.62 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.67 Mn |
| Mar 31, 2026 | 8.85 Mn |
| Dec 31, 2025 | 15.73 Mn |
| Sep 30, 2025 | 56.59 Mn |
| Jun 30, 2025 | 100.20 Mn |
| Mar 31, 2025 | 127.79 Mn |
| Dec 31, 2024 | 107.53 Mn |
| Sep 30, 2022 | 282,000.00 |
| Jun 30, 2020 | 4.00 Mn |
| Mar 31, 2020 | 31.97 Mn |
| Dec 31, 2019 | 72.75 Mn |
| Sep 30, 2019 | 124.26 Mn |
| Jun 30, 2019 | 107.71 Mn |
| Mar 31, 2019 | 127.03 Mn |
| Dec 31, 2018 | 52.49 Mn |
| Sep 30, 2018 | 6.87 Mn |
| Jun 30, 2018 | 20.32 Mn |
| Mar 31, 2018 | 29.32 Mn |
| Dec 31, 2017 | 55.74 Mn |
| Sep 30, 2017 | 29.78 Mn |